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Abstract Fibrillins are extracellular, disulphide-rich
glycoproteins that form 10–12 nm diameter microfibrils in
connective tissues. They are found in the majority of higher
animals, from jellyfish to humans. Fibrillin microfibrils
confer properties of elasticity and strength on connective
tissue and regulate growth factor availability in the extra-
cellular matrix (ECM). Mutations in FBN1, the human
gene encoding the fibrillin-1 isoform, are linked to several
inherited connective tissue disorders. The fibrillin-1
N-terminus forms many functionally-important interac-
tions, both with other fibrillin molecules and various ECM
components. In particular, the first four domains, the
fibrillin unique N-terminal (FUN) and three epidermal
growth factor (EGF)-like domains (FUN-EGF3), are
implicated in microfibril assembly and growth factor
sequestration. The structure of these domains, which
comprise 134 residues, is unknown. We have produced a
recombinant fragment corresponding to this region of
human fibrillin-1. Here, we report 1H, 13C and 15N reso-
nance assignments of the FUN-EGF3 fragment. Assign-
ments will facilitate structure determination, analysis of
interdomain dynamics and the mapping of interaction
surfaces.
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Biological context
Fibrillin microfibrils are essential structural and regulatory
components of the extracellular matrix (ECM) in connec-
tive tissues. They are found in elastic tissues, such as the
skin, blood vessels and lungs, as part of elastic fibres,
in which they surround an amorphous network of elastin
(Sakai et al. 1986). Microfibrils are also present in non-
elastic connective tissues such as the ciliary zonules of the
eye and kidney glomerulus, which do not contain elastin. In
both cases, microfibrils are important for strength and
elasticity. Furthermore, they regulate the availability of
transforming growth factor-beta (TGFb) family signalling
molecules through sequestration of their latent forms (Ra-
mirez and Rifkin 2009). When extracted from tissue and
visualised by electron or atomic force microscopy, micro-
fibrils have a diameter of 10–12 nm and a beaded filament
structure, with an average distance of *56 nm between the
beads (Sakai et al. 1991, Hanssen et al. 1998).
Fibrillins, the major structural components of microfi-
brils, are disulphide-rich glycoproteins found in most
eumetazoa (Robertson et al. 2011). Their domain organi-
sation is modular and highly conserved, with a high
abundance of calcium-binding epidermal growth factor-
like (cbEGF) domains, as well as several non-calcium EGF
domains (Fig. 1). Arrays of cbEGF domains are inter-
spersed by TGFb binding-like (TB) and hybrid (hyb)
domains, as well as a proline- or glycine-rich region,
depending on the isoform. The structures of many of these
domain types have been determined by X-ray crystallog-
raphy and NMR spectroscopy (Knott et al. 1996, Yuan
et al. 1997, Lee et al. 2004, Jensen et al. 2009). However,
detailed structural information about the N- and C-terminal
regions, including the fibrillin unique N-terminal (FUN)
domain, is still lacking. High-resolution structures are
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important for understanding how fibrillin monomers
assemble into microfibrils, the arrangements they form in
microfibrils, their interactions with other ECM components
and the effects of disease-causing mutations. Several
inherited connective tissue disorders are linked to muta-
tions in the human FBN1 gene, which encodes fibrillin-1:
for example, Marfan syndrome (Lee et al. 1991), stiff skin
syndrome (Loeys et al. 2010), acromicric and geleophysic
dysplasias (Le Goff et al. 2011) and Weill-Marchesani
syndrome (Faivre et al. 2003).
The fibrillin N-terminus is functionally versatile, interact-
ing with many ECM components. It has been suggested that an
important step in microfibril assembly is the interaction
between the N- and C-terminal regions of fibrillin monomers.
Several studies have demonstrated such interactions (Lin et al.
2002, Marson et al. 2005, Hubmacher et al. 2008). The min-
imal regions needed for the N–C terminal interaction have
been identified: the four N-terminal domains (FUN-EGF3),
starting after the furin proteolytic cleavage site, and the last
three cbEGF domains (cbEGF41–cbEGF43) at the C-termi-
nus (El-Hallous et al. 2007, Hubmacher et al. 2008). The
FUN-EGF3 region is also a minimal interaction site for the
prodomains of bone morphogenetic proteins-5 (Sengle et al.
2011) and -7 (Sengle et al. 2008). As a first step towards
structural analysis of this region, a recombinant FUN-EGF3
fragment was produced. 1H, 13C and 15N resonance assign-
ments for the protein are reported here.
Methods and experiments
Protein expression, purification and refolding
Protein expression and purification was carried out as
described previously (Knott et al. 1996) with modifications.
Escherichia coli BL21 cells, also containing the pREP4
plasmid (Qiagen) encoding the lacI repressor, were trans-
formed with the pQE-30 expression vector (Qiagen) con-
taining the human fibrillin-1 FUN-EGF3 sequence. The
native fibrillin sequence started at residue R45 (numbered
according to Pereira et al. 1993), the first residue after the
furin proteolytic cleavage site, and finished at Q178, the
residue after the last cysteine in the EGF3 domain. An
N-terminal His6 tag was present for purification, followed
by a factor Xa protease recognition site (I-E-G-R) to allow
His6 tag removal and an S–A spacer before the start of the
FUN-EGF3 sequence. 15N/13C-double labelled protein was
produced by growing cells in M9 medium containing 0.1 %
(w/v) 15NH4Cl and 0.5 % (w/v)
13C-glucose (Cambridge
Isotope Laboratories), with the addition of 100 lg/ml
ampicillin and 25 lg/ml kanamycin. 50 ml of starter culture,
grown in labelled medium at 37 C for*18 h, was added to
0.6 l of medium. Cells were grown to OD600 *0.8 and
expression was induced with isopropyl-b-D-thiogalactopy-
ranoside (IPTG) at a final concentration of 2 mM. Cells were
incubated at 28 C for at least 6 h, harvested by centrifuga-
tion and stored at -80 C until protein purification.
Cells were initially lysed in buffer containing 50 mM
sodium phosphate pH 7.4, 6 M guanidinium chloride and
5 mM 2-mercaptoethanol (lysis buffer). Insoluble material
was pelleted by ultracentrifugation (40,000 rpm; Beck-
mann 60Ti rotor; 25 C; 30 min). The insoluble material
was resuspended in lysis buffer. 2-mercaptoethanol was
added to the suspension (concentration increase of
0.3 mM) and the pH was raised to *9.0 with the addition
of NaOH, followed by vigorous mixing by vortexing. The
pH was then lowered to pH *7.4 using HCl and the
solution was centrifuged again. Cleared lysate was loaded
onto fast flow chelating Sepharose (GE Healthcare) pre-
loaded with Ni2? and pre-equilibrated with lysis buffer.
The column was then washed extensively with lysis
buffer. Protein was eluted from the column in lysis buffer
also containing 50 mM ethylenediaminetetraacetic acid
(EDTA) and 100 mM dithiothreitol (DTT). Tris–HCl pH
8.3 was added to the eluted protein at a final concentration
of 100 mM and additional DTT to final concentration of
200 mM. Following incubation at room temperature for
1 h, the mixture was adjusted to pH *3.0 and dialysed
Fig. 1 Domain organisation of
human fibrillin-1. Fibrillins
have two furin-cleavage sites—
one at the N-terminus preceding
the FUN domain and one in the
unique C-terminal domain. The
fragment under study (FUN-
EGF3), which begins after the
first furin recognition site, is
highlighted
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overnight against 0.1 % (v/v) trifluoracetic acid (TFA).
Protein was then desalted by reverse phase high perfor-
mance liquid chromatography (HPLC).
Purified, reduced protein was refolded under the fol-
lowing conditions: 100 mM Tris–HCl pH 8.3, 3 mM
L-cysteine, 0.3 mM L-cystine, 50 % (v/v) glycerol, 0.2 mg/ml
protein at 4 C for *72 h. The refolding mixture was
acidified to pH *3.0 and dialysed against 0.1 % (v/v) TFA
for at least 5 h. Protein was then concentrated by ultrafil-
tration and purified by HPLC. The His6 tag was removed
through treatment with factor Xa (Novagen) under the
conditions: 20 mM 2-(N-Morpholino) ethanesulfonic acid
pH 5.8, 100 mM NaCl, *4 mg/ml protein, 1 unit factor
Xa/mg protein. Protein was further purified by cation
exchange fast liquid protein chromatography and HPLC.
The final product was analysed by denaturing SDS-PAGE
in the presence or absence of 5 % (v/v) 2-mercaptoethanol,
as well as by electrospray ionisation mass spectrometry
(observed mass of unlabelled protein is 14,082 Da).
NMR spectroscopy
Experiments for assignment were performed using 15N-
single or 15N/13C-double labelled FUN-EGF3 at a con-
centration of 0.5–1.5 mM in 5 % D2O/95 % H2O (v/v) at
pH 5.4. NMR experiments were carried out at 298 K on
three different spectrometers: home-built spectrometers
with 1H-operating frequencies of 600 MHz or 750 MHz, a
triple-resonance probe and GE/Omega console, or a Bruker
Avance 500 MHz spectrometer with a Cryoplatform,
equipped with a TCI CryoProbe. Initial sequential assign-
ments were obtained with data from 3D 15N-edited TOC-
SY-HSQC, NOESY-HSQC and HSQC-NOESY-HSQC
experiments acquired using 15N-labelled protein. Assign-
ments were confirmed and extended using 3D HNCA,
(H)CC(CO)NH, HNCO and HN(CA)CO experiments with
15N/13C-double labelled FUN-EGF3. Side-chain assign-
ments were obtained using the above experiments, as well
as 3D HCCH-TOCSY, 3D 13C-edited NOESY-HSQC, 2D
1H-13C(aromatic) HSQC, 2D 1H NOESY, 2D 1H DQF-
COSY and 2D 1H TOCSY. NMR data were processed
using NMRPipe (Delaglio et al. 1995) and analysed using
CcpNmr Analysis (Vranken et al. 2005).
Assignments and data deposition
Resonances were assigned for all 134 residues in the native
sequence, starting at R45. Figure 2 shows a 1H-15N HSQC
spectrum of FUN-EGF3. All non-proline backbone 1HN and
Fig. 2 750 MHz 1H-15N HSQC spectrum of 15N-labelled FUN-
EGF3 in 5 % D2O/95 % H2O at pH 5.4 and 298 K. Peak assignments
for backbone amides and the W71 Ne1-He1 peak are shown. The
NH2 side-chain peaks of N57 and N125 are also indicated by red
circles. Assignments are not shown for overlapping peaks. The boxed
region marked * is annotated separately on the lower right-hand side
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15N resonances were assigned except C119 and T173. 15N
assignments of the 10 proline residues were not obtained.
Overall, 97.3 % of all 1H assignments were obtained,
including 100 % of 1Ha, 99.0 % of 1Hb, 100 % of 1Hc and
97.6 % of 1Hd. 89.9 % of 13C resonance assignments were
obtained, including 100 % of 13Ca, 99.1 % of 13Cb and
100 % of 13C0. Complete proline side-chain 1H and 13C
assignments were obtained. The remaining unassigned 1H
and 13C resonances are mainly in aromatic side chains.
Several unusual chemical shifts were measured, most
likely arising from the proximity of these nuclei to aro-
matic rings. The 1Hd2 side-chain resonances of N57 are
upfield-shifted, with chemical shifts of 5.05 and 6.09 ppm
(Fig. 2). NOESY data indicate that the side chain of N57 in
the FUN domain is close to the W71 aromatic ring, also in
the FUN domain (data not shown). The 1Hb resonance of
T101 in the EGF1 domain is also upfield-shifted
(2.76 ppm)—the atom is likely to lie above the plane of the
aromatic ring of F93 (data not shown). In addition, the
15Nd resonance of N125 in the EGF2 domain is downfield-
shifted, with a chemical shift of 118.35 ppm (Fig. 2).
Secondary chemical shifts (Fig. 3a-d) indicate that the
majority of residues are in structured regions of FUN-EGF3,
as the values differ from random coil chemical shifts. They
were used to make predictions about the structure and
dynamics of the protein. Figure 3e shows a plot of predicted
Fig. 3 Analysis of FUN-EGF3
chemical shifts. Domains,
defined by exon boundaries in
the FBN1 gene (Pereira et al.
1993), are indicated by coloured
boxes above the plots. a 13C0
secondary chemical shifts
plotted as a function of residue
number. b 13Ca secondary
chemical shifts. c 13Cb
secondary chemical shifts d 1Ha
secondary chemical shifts.
e Random coil index (RCI)
order parameters (S2) predicted
from chemical shifts, plotted as
a function of residue number.
Predictions were made using the
TALOS? and MICS servers
(Shen et al. 2009, Shen and Bax
2012), using the method of
Berjanskii and Wishart (2005).
f Secondary structure prediction
by TALOS?/MICS. Bars
indicate the predicted secondary
structure adopted by each
residue, with the height showing
the prediction probability.
Positive values and blue bars
indicate extended (b-strand)
structure, while negative values
and red bars indicate helical
(a-helix) structure. Residues
without bars are predicted to
occur in loops, turns or regions
with random-coil structure
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order parameters (S2), on the basis of the random coil
index (Berjanskii and Wishart 2005, Shen et al. 2009, Shen
and Bax 2012), against residue number. The predictions
identify several potentially flexible regions in the structure:
firstly, the N-terminal residues (R45-G55) have predicted
S2 \ 0.8; secondly, residues in the linker sequence between
the last cysteine of the EGF1 domain and first cysteine of
EGF2 (G112-H118) all have predicted S2 \ 0.5. Thirdly,
residues at the C-terminus of the EGF3 domain, after the
penultimate cysteine (T169-E178) may be more flexible, all
having predicted S2 \ 0.8. In the full-length fibrillin molecule
this loop may pack against the hyb1 domain, which follows
the EGF3 domain in the amino acid sequence. There is also
variability in the predicted S2 value in other regions of the
structure-residues with lower values may lie in flexible loops.
Chemical shift-based predictions by TALOS? (Shen
et al. 2009) and MICS (Shen and Bax 2012) suggest that there
are no long, continuous regions of regular secondary struc-
ture in FUN-EGF3 (Fig. 3f). However, there are several
stretches of two to three residues with predicted b-sheet-like
structure. These mainly coincide with the expected locations
of b-hairpin structures, which are typically found in EGF-
like domains (Bork et al. 1996). For example, residues R159-
V161 and R165-A167 in the EGF3 domain are expected to
form a two-stranded b-sheet. Only two residues, C150 and
E151 in the EGF3 domain, are predicted to adopt a-helical
secondary structure. EGF-like domains typically have only
small regions of regular secondary structure, but are stabi-
lised by the presence of three disulphide bonds. The FUN
domain, which has an unknown structure, is also predicted to
contain little secondary structure, with short b-sheet-like
elements. It has four cysteine residues, which may form two
disulphide bonds. In future, structure determination of the
FUN-EGF3 fragment and characterisation of its dynamics
will shed further light on the properties on the FUN domain
and the interdomain interfaces.
The chemical shift assignments for FUN-EGF3 have been
deposited in the BioMagResBank (http://www.bmrb.wisc.
edu) under the accession number 18843.
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